Birznieks Gunther
CIK 0001702031
SVP, Business Development
Filings
9
Latest Mar 4, 2026
Issuers covered
1
Showing
9 of 9
Page 1
Track record
7 of 7 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 7 | 29% | -6.5% | -7.4% | +13.5% | -18.8% |
| 90 days | 7 | 71% | +2.2% | +7.4% | +21.1% | -23.7% |
| 180 days | 6 | 67% | +0.3% | +7.1% | +16.0% | -22.7% |
| 365 days | 6 | 67% | +18.3% | +30.0% | +43.4% | -23.9% |
Issuers
Companies where Birznieks Gunther has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | 9 | Mar 4, 2026 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|